ID: ALA2236693
Chembl Id: CHEMBL2236693
PubChem CID: 76326192
Max Phase: Preclinical
Molecular Formula: C12H9N3O3
Molecular Weight: 243.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc2cc3c(=O)[nH]c(=O)[nH]c3nc12
Standard InChI: InChI=1S/C12H9N3O3/c1-18-8-4-2-3-6-5-7-10(13-9(6)8)14-12(17)15-11(7)16/h2-5H,1H3,(H2,13,14,15,16,17)
Standard InChI Key: DBDWSDKWBWTJFW-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 243.22 | Molecular Weight (Monoisotopic): 243.0644 | AlogP: 0.77 | #Rotatable Bonds: 1 |
| Polar Surface Area: 87.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 9.29 | CX Basic pKa: 0.34 | CX LogP: 1.99 | CX LogD: 1.99 |
| Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.62 | Np Likeness Score: -0.63 |
| 1. Nadaraj V, Selvi ST, Mohan S, Thangadurai TD. (2012) Microwave-assisted synthesis and pharmacological studies of novel 5-deazaalloxazine derivatives, 21 (10): [10.1007/s00044-011-9811-1] |
Source(1):
